HOME >> BIOLOGY >> NEWS
Whitaker Foundation funds Washington University biomedical engineering facility

me a national leader in an important field that is bringing to the world breakthroughs in human health every day."

"We are extremely pleased to have the support of The Whitaker Foundation to build a world-class biomedical engineering department," stated Frank C.P. Yin, M.D., Ph.D., chair of the department and director of the university's Institute of Biological and Medical Engineering. (Yin also is Steven F. and Camilla T. Brauer Professor of Biomedical Engineering.) "We will be recruiting a mix of outstanding senior and junior faculty. Once the building and the new faculty are in place, we will be more than ready to meet the demand for biomedical engineering, which already is extremely popular with our students."

Christopher I. Byrnes, dean of the School of Engineering and Applied Sciences, said this high demand was anticipated early on in the planning for the 21st century. "The need for a strong biomedical engineering department was identified as one of the school's top priorities during our Project 21 planning process," Byrnes noted.

Recognizing the need to begin building a biomedical engineering center, the new department was introduced in the fall of 1997, with 50 freshman students expressing an interest in a major. This fall, nearly one-third of the 270 incoming engineering freshmen have declared an interest in the biomedical engineering major. Roughly half of the engineering students earning a bachelor's degree pursue a medical degree, with the other half going into industry or academia. The department currently enrolls 29 graduate students, 19 doctoral candidates and 10 master's degree students.

"The Biomedical Engineering department has been growing steadily, with the resulting growing pains," said Byrnes. "The Foundation's awards will transform the young department with limited space into a major center of research and teaching."

While the young department is small, with a core faculty of five full-time
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
4-Nov-1999


Page: 1 2 3 4

Related biology news :

1. Whitaker Foundation to phase out grant programs
2. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
3. Whitaker makes largest individual grants ever totaling more than $30 million
4. Whitaker Foundation To Fund AAAS Science Journalism Awards Through 2001
5. Whitaker Awards $6.8 Million For Biomedical Engineering Education
6. Brown ecologist garners major National Science Foundation grant
7. APS Foundation names student travel award recipients
8. Institute for OneWorld Health receives Gates Foundation grant
9. National Parkinson Foundation designates UNC as Center of Excellence
10. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
11. Leslie Ann Schiff wins 2004 Carski Foundation Award

Post Your Comments:
(Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
(Date:4/17/2014)... channels are implicated in many serious conditions such as ... potential target for drug therapies. Unfortunately, there is still ... Cambridge research provides fresh and unexpected insight into the ... components - β-subunit molecules - which are responsible for ... published in the most recent edition of the ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: